Evidence map›Paper›PMID 34184839›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2021

Mucin-Like Glycoproteins Modulate Interfacial Properties of a Mimetic Ocular Epithelial Surface.

Chunzi Liu, Amy C Madl, Daniel Cirera-Salinas, Wolfgang Kress, Frank Straube, David Myung, Gerald G Fuller

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Elucidating the roles of electrolytes and hydrogen bonding in the dewetting dynamics of the tear film.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  7. Article
  8. Effect of Recombinant Human Lubricin on Model Tear Film Stability.Translational vision science & technology · 2022
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Chunzi LiuDepartment of Chemical Engineering, Stanford University, Stanford, CA, 94305, USA.ORCID 0000-0002-3469-3904
Amy C MadlDepartment of Chemical Engineering, Stanford University, Stanford, CA, 94305, USA.
Daniel Cirera-SalinasGlobal Drug Development, Biopharmaceutical Process & Product Development, Novartis Pharma, Basel, AG 4002, Switzerland.
Wolfgang KressGlobal Drug Development, Biopharmaceutical Process & Product Development, Novartis Pharma, Basel, AG 4002, Switzerland.
Frank StraubeGlobal Drug Development, Biopharmaceutical Process & Product Development, Novartis Pharma, Basel, AG 4002, Switzerland.
David MyungDepartment of Chemical Engineering, Stanford University, Stanford, CA, 94305, USA.
Gerald G FullerDepartment of Chemical Engineering, Stanford University, Stanford, CA, 94305, USA.
Stanford University · USNovartis (Switzerland) · CH

Funding

Stanford Vision Research CoreP30EY026877 · NEI · STANFORD UNIVERSITY · PI Jeffrey L Goldberg · 2017 to 2026
$8.0M
In Situ Bioconjugation as a Therapeutic Delivery Modality to Enhance Ocular Wound HealingK08EY028176 · NEI · STANFORD UNIVERSITY · PI MYUNG, DAVID · 2017 to 2021
$1.1M
Bio-AFM for combined light and atomic force imagingS10OD021514 · OD · STANFORD UNIVERSITY · PI DUNN, ALEXANDER R · 2016 to 2016
$513k
E. Matilda Ziegler Foundation for the BlindFleiszig Lab at the University of CaliforniaNational Science Foundation ECCS-1542152NCRR NIH HHSNEI NIH HHS K08 EY028176NEI NIH HHS P30 EY026877NIH HHS K08EY028176NIH HHS P30-EY026877NIH HHS S10 OD021514Research to Prevent Blindness
6 · The paper itself

Abstract

Dry eye disease (DED) has high personal and societal costs, but its pathology remains elusive due to intertwined biophysical and biochemical processes at the ocular surface. Specifically, mucin deficiency is reported in a subset of DED patients, but its effects on ocular interfacial properties remain unclear. Herein a novel in vitro mucin-deficient mimetic ocular surface (Mu-DeMOS) with a controllable amount of membrane-tethered mucin molecules is developed to represent the diseased ocular surfaces. Contact angle goniometry on mimetic ocular surfaces reveals that high surface roughness, but not the presence of hydrophilic mucin molecules, delivers constant hydration over native ocular surface epithelia. Live-cell rheometry confirms that the presence of mucin-like glycoproteins on ocular epithelial cells reduces shear adhesive strength at cellular interfaces. Together, optimal surface roughness and surface chemistry facilitate sustainable lubrication for healthy ocular surfaces, while an imbalance between them contributes to lubrication-related dysfunction at diseased ocular epithelial surfaces. Furthermore, the restoration of low adhesive strength at Mu-DeMOS interfaces through a mucin-like glycoprotein, recombinant human lubricin, suggests that increased frictional damage at mucin-deficient cellular surfaces may be reversible. More broadly, these results demonstrate that Mu-DeMOS is a promising platform for drug screening assays and fundamental studies on ocular physiology.

Indexed as

Ocular Physiological PhenomenaAnimalsCells, CulturedDry Eye SyndromesEpithelial CellsGlycoproteinsHumansMucinsGlycoproteinsMucinscontact angle hysteresisdry eye diseaseinterfacial propertieslubricinmuco-adhesionocular surfaces

Identifiers

PMID34184839
PMCPMC8373091
OpenAlexW3174670673

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.